Ibtihaj Fughhi

University of Louisville — United States

Medicine · Health Sciences

13h-index457citations50works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cardiac Imaging and Diagnostics(12), Cancer Immunotherapy and Biomarkers(10), Advanced MRI Techniques and Applications(10), Inflammatory Biomarkers in Disease Prognosis(8), Cardiac electrophysiology and arrhythmias(7)

Publications50 total

+Racial Inequities in Coronary Artery Calcium Screening and Follow-up
Journal of clinical lipidology·2024
ASCVD RISK PREDICTION AMONG DIVERSE RACIAL POPULATIONS - POOLED COHORT EQUATIONS (PCE) VS. CORONARY ARTERY CALCIUM SCORING (CACS)
Journal of the American College of Cardiology·2024
RACIAL DISPARITIES IN ACCESS TO CORONARY ARTERY CALCIUM SCORING (CACS) AND SUBSEQUENT CARDIOVASCULAR CARE
Journal of the American College of Cardiology·2024
Nutrition Intervention for Reduction of Cardiovascular Risk in African Americans Using the 2019 American College of Cardiology/American Heart Association Primary Prevention Guidelines
Nutrients·2021· 11 citedOpen Access
Associations between sinus tachycardia and adverse cardiovascular outcomes and mortality in cancer patients
Journal of Thoracic Disease·2021· 13 citedOpen Access
Associations Between Sinus Tachycardia and Adverse Cardiovascular Outcomes and Mortality in Cancer Patients
Research Square (Research Square)·2021· 2 citedOpen Access
Derangements in Coronary Calcium Score and Left Ventricular Global Longitudinal Strain in Patients Post Left Breast Radiotherapy
Research Square (Research Square)·2020Open Access
Abstract 15246: Nutrition Intervention, Lipids and Biomarkers of Risk in African Americans: Help Everyone Assess Risk Today: Lenten Nutrition Study: “Giving up Unhealthy Food for Lent”
Circulation·2019· 1 cited
Abstract 14778: Reduction of Cardiometabolic Risk in African Americans Utilizing the 2019 American College of Cardiology/American Heart Association Primary Prevention Nutrition Guidelines
Circulation·2019
Abstract 16318: Impact of a Plant-Based Nutrition Intervention on the 10-Year Ascvd Risk in African Americans
Circulation·2019
Influence of breast reconstruction on technical aspects of echocardiographic image acquisition compared with physician-assessed image quality
Cardio-Oncology·2019· 3 citedOpen Access
P1.05 Clinical Factors Associated with Progression in Previously Treated Patients with Metastatic NSCLC on ANTI-PD-1 Therapy
Journal of Thoracic Oncology·2019Open Access
Bioinformatics Model of Serum Biomarkers to Prognosticate the Response to Programmed Death-1/Ligand-1 Targeted Immunotherapy in Metastatic Non–Small Cell Lung Cancer
American Journal of Clinical Pathology·2019
Abstract 404: Prognostic value of soluble and cell surface immune-checkpoint molecules in advanced non-small cell lung cancer (NSCLC) patients receiving anti-PD-1/-L1 immunotherapy
Cancer Research·2019
Abstract 404: Prognostic value of soluble and cell surface immune-checkpoint molecules in advanced non-small cell lung cancer (NSCLC) patients receiving anti-PD-1/-L1 immunotherapy
Clinical Research (Excluding Clinical Trials)·2019
Associations between baseline serum biomarker levels and cachexia/precachexia in pretreated non-small cell lung cancer (NSCLC) patients.
Journal of Clinical Oncology·2019· 1 cited
Decreasing BMI/weight immediately prior to starting anti-PD-1/PDL-1 monoclonal antibodies for treatment for stage IV non-small cell lung cancer is associated with shorter progression-free survival.
Journal of Clinical Oncology·2019· 2 cited
Mature, real world progression-free survival (PFS) and overall survival (OS) milestones in stage IV, non-squamous, non-small cell lung cancer patients (nsqNSCLC) treated with first line pemetrexed(Pem)/platinum(Plat) followed by pem+/-bevacizumab(Bev) maintenance.
Journal of Clinical Oncology·2019
ELEVATED RESTING HEART RATE IMPROVES RISK STRATIFICATION FOR ADVERSE CARDIOVASCULAR OUTCOMES IN CANCER PATIENTS
Journal of the American College of Cardiology·2019
P2.01-61 Body Mass Index over Time is Associated with Overall Survival in Advanced NSCLC Patients Treated with Immunotherapy.
Journal of Thoracic Oncology·2018· 6 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Sanjib Basu(19), Philip Bonomi(19), Jeffrey A. Borgia(18), Mary J. Fidler(17), Marta Batus(17), Rami Doukky(15), Tania Campagnoli(10), Marwan Wassouf(8), Amjad Ali(7), Chiedozie Anokwute(6), Michael Kharouta(5), Aviral Vij(5), Andrew Appis(5), Parva Bhatt(5), Imad Tarhoni(5), Palmi Shah(4), Javier Gómez(4), Mohamad Hemu(4), Megan Randall(4), Andres Palomo(4)